Psychopharmacological effects of pyritinol in normal volunteers.

Hindmarch I, Coleston DM, Kerr JS.

HPRU, Robens Institute, 
University of Surrey, Guildford, UK.
Neuropsychobiology 1990-91;24(3):159-64

ABSTRACT

Twelve healthy male volunteers received pyritinol 600 or 1,200 mg or placebo for 3 days according to a randomised, double-blind crossover design. On the 1st and 3rd days of each of the three treatment periods subjects completed a battery of psychological tests including Critical Flicker Fusion (CFFT), Choice Reaction Time (CRT), tests of memory and subjective drug effects at 1, 2, 4 and 6 h after dosing. Significant improvements in CFFT and CRT were found after pyritinol. There were no significant differences on the other tests, however, the observed enhancement in performance could be attributed to the effect of the drug.

Galantamine | Idebenone | diabetes | Vinpocetine | stroke | Modafinil
Deprenyl | Piracetam | Picamilon
| CDP Choline 
| Memantine | cataract
HomeOrder
www.AlzheimersTreatments.com


1.     pyritinol  and coma
2.     pyritinol  and head injury
3.     pyritinol  and rheumatoid arthritis
4.     pyritinol  and memory
5.     pyritinol  as a free radical scavenger
6.     pyritinol  and dementia
7.     pyritinol  and dementia
8.     pyritinol  and Alzheimer's
9.     pyritinol  stimulation of neutrophils
10.   pyritinol  vs. Hydergine
11.   pyritinol  and phosphatidylserine
12.   pyritinol  and phosphatidylinositol
13.   pyritinol  and dementia
14.   pyritinol  neurochemical studies
15.   pyritinol  mental disorders
16.   pyritinol  learning by Swiss albino mice
 

 

 

Hit Counter